Samlyn Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-215,300
Closed -$35.3M 161
2020
Q2
$35.3M Buy
+215,300
New +$33M 0.65% 49

Other funds holding LLY

Samlyn Capital's LLY Position: Q2 2026 in Review

Samlyn Capital reduced its Eli Lilly (LLY) stake by 48% in Q2 2026, selling an estimated $34.8M and leaving 37,125 shares worth $44.5M. The position accounts for 0.73% of the portfolio, ranked #44.

Samlyn Capital first reported a position in LLY in Q1 2021 and has held it in 5 quarters since. The position peaked at $92M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Samlyn Capital held 37,125 shares of Eli Lilly worth $44.5M as of Q2 2026.
  • Samlyn Capital sold 34,019 Eli Lilly shares in Q2 2026, an estimated $34.8M.
  • Eli Lilly made up 0.73% of Samlyn Capital's portfolio in Q2 2026, its #44 holding.
  • Samlyn Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 5 quarters since.
  • Samlyn Capital's Eli Lilly position peaked at $92M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.